|
2024
|
Invention
|
Azithromycin and roxithromycin derivatives as senolytic drugs.
This disclosure describes the use... |
|
|
Invention
|
Mitochondria specific transcription inhibitor compounds. Mitochondria specific transcription inhi... |
|
|
Invention
|
Mitochondria specific transcription inhibitors. Mitochondria specific transcription inhibitors ma... |
|
|
Invention
|
Azithromycin and roxithromycin derivtives as senolytic drugs. This disclosure describes the use o... |
|
|
Invention
|
Triple combination therapies for anti-aging.
The present approach effectively eradicates senesce... |
|
2023
|
Invention
|
Selective cdk 4/6 inhibitor cancer therapeutics.
This disclosure describes embodiments of select... |
|
|
Invention
|
Macrolide senolytic compounds |
|
|
Invention
|
Macrolide senolytic compounds. Disclosed herein are macrolide compounds having senolytic activity... |
|
|
Invention
|
2-[(2-oxo-4-phenyl-2h-chromen-7-yl)oxy] propanamido derivatives |
|
|
Invention
|
2-[(2-oxo-4-phenyl-2h-chromen-7-yl)oxy] propanamido derivatives. Disclosed are 2-[(2-Oxo-4-phenyl... |
|
2022
|
Invention
|
Mitochondrial atp inhibitors targeting the gamma subunit prevent metastasis.
High ATP production... |
|
|
Invention
|
Mitochondrial atp inhibitors targeting the gamma subunit prevent metastasis |
|
|
Invention
|
Mitochondrial atp inhibitors targeting the gamma subunit prevent metastasis. High ATP production ... |
|
|
Invention
|
Energetic cancer stem cells (e-cscs): a new hyper-metabolic and proliferative tumor cell phenotyp... |
|
|
Invention
|
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic ... |
|
2021
|
Invention
|
Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angi... |
|
|
Invention
|
Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cel... |
|
|
Invention
|
Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells.... |
|
|
Invention
|
Selective cdk4/6 inhibitor cancer therapeutics. This disclosure describes embodiments of selectiv... |
|
|
Invention
|
Myristoyl derivatives of 9-amino-doxycycline for targeting cancer stem cells and preventing metas... |
|
|
Invention
|
Therapeutic methods for preventing tumor metastasis and tumor recurrence.
Cancer stem cells are ... |
|
|
Invention
|
Therapeutic methods for preventing tumor metastasis and tumor recurrence. Cancer stem cells are r... |
|
|
Invention
|
Triphenylphosphonium-derivative compounds for eradicating cancer stem cells. Tri-phenyl-phosphoni... |
|
2020
|
Invention
|
Selective cdk4/6 inhibitor cancer therapeutics.
This disclosure describes selective and potent C... |
|
|
Invention
|
Selective cdk 4/6 inhibitor cancer therapeutics.
The disclosure describes selective and potent C... |
|
|
Invention
|
Selective cdk4/6 inhibitor cancer therapeutics. This disclosure describes selective and potent CD... |
|
|
Invention
|
Selective cdk4/6 inhibitor cancer therapeutics. The disclosure describes selective and potent CDK... |
|
|
Invention
|
Atp-based cell sorting and hyperproliferative cancer stem cells.
High mitochondrial ATP is a met... |
|
|
Invention
|
Atp-based cell sorting and hyperproliferative cancer stem cells. High mitochondrial ATP is a meta... |
|
|
Invention
|
Carbocyanine compounds for targeting mitochondria and eradicating cancer stem cells.
Certain car... |
|
|
Invention
|
Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer. MCF... |
|
|
Invention
|
Alkyl-tpp compounds for mitochondria targeting and anti-cancer treatments.
Alkyl-triphenylphosph... |
|
2019
|
Invention
|
Triple combination therapies for targeting mitochondria and killing cancer stem cells.
Cancer st... |
|
|
Invention
|
Triple combination therapies for anti-aging. The present approach effectively eradicates senescen... |
|
|
Invention
|
Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic y... |
|
|
Invention
|
Azithromycin and roxithromycin derivatives as senolytic drugs. This disclosure describes the use ... |
|
|
Invention
|
Biomarkers and therapeutics for endocrine therapy resistance. Cancer cells can develop resistance... |
|
2018
|
Invention
|
Targeting mitochondrial fission through mdivi-1 derivatives. Derivatives of mDIVI-1 may be used t... |
